1986PubMedRequires access

[Contraceptive agents and antithrombin III. New causes of thrombosis].

Ulrik Abildgaard, Andersson Tr, K Try, Odegaard Or

Open publisher page 0 citations

Abstract

In response to an article on the effect of contraceptive agents on antithrombin III the role of other coagulation inhibitors in inducing thrombosis is stressed namely protein C and heparin cofactor II. Deficiency of both protein C and heparin cofactor II leads to deep venous thrombosis. In 10 to 15% of deep venous thrombosis cases deficiency of antithrombin or protein C was the underlying cause according to research data. Congenital protein C deficiency is more frequent than antithrombin deficiency. Protein C levels were measured from 1983 using immunochemical methods and after 1985 using independently designed methods. The results showed deficient conditions in many Norwegian families. As warfarin reduces the blood concentration of protein C low warfarin doses and effective heparin treatment must be assured when patients are treated for protein C deficieny. In conclusion the importance of measurement of blood coagulation inhibitors (antithrombin protein C heparin cofactor II) in those susceptible to deep venous thrombosis is emphasized.

About this research paper

What this paper is about

In response to an article on the effect of contraceptive agents on antithrombin III the role of other coagulation inhibitors in inducing thrombosis is stressed namely protein C and heparin cofactor II. Deficiency of both protein C and heparin cofactor II leads to deep venous thrombosis. In 10 to 15% of deep venous thrombosis cases deficiency of antithrombin or protein C was the underlying cause according to research data. Congenital protein C deficiency is more frequent than antithrombin deficiency. Protein C levels were measured from 1983 using immunochemical methods and after 1985 using independently designed methods. The results showed deficient conditions in many Norwegian families. As warfarin reduces the blood concentration of protein C low warfarin doses and effective heparin treatment must be assured when patients are treated for protein C deficieny. In conclusion the importance of measurement of blood coagulation inhibitors (antithrombin protein C heparin cofactor II) in those susceptible to deep venous thrombosis is emphasized.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In response to an article on the effect of contraceptive agents on antithrombin III the role of other coagulation inhibitors in inducing thrombosis is stressed namely protein C and heparin cofactor II. Deficiency of both protein C and heparin cofactor II leads to deep venous thrombosis. In 10 to 15% of deep venous thrombosis cases deficiency of antithrombin or protein C was the underlying cause according to research data. Congenital protein C deficiency is more frequent than antithrombin deficiency. Protein C levels were measured from 1983 using immunochemical methods and after 1985 using independently designed methods. The results showed deficient conditions in many Norwegian families. As warfarin reduces the blood concentration of protein C low warfarin doses and effective heparin treatment must be assured when patients are treated for protein C deficieny. In conclusion the importance of measurement of blood coagulation inhibitors (antithrombin protein C heparin cofactor II) in those susceptible to deep venous thrombosis is emphasized.

Key concepts: Antithrombin, Heparin cofactor II, Heparin, Protein C, Thrombosis, Coagulation, Warfarin, Venous thrombosis

Related papers

Back to paper searchBrowse research topicsOriginal source
[Contraceptive agents and antithrombin III. New causes of thrombosis]. — Research Paper | ScholarLens